Chelation Infusions (CaEDTA, NaEDTA, DMPS)
Toxins like lead, mercury, and cadmium can accumulate in your body over time, causing fatigue, brain fog, and even chronic diseases. Chelation infusions use FDA-approved agents to bind to these harmful metals, safely eliminating them through your body’s natural detox pathways.
At Swissmed Health, our chelation therapy is tailored to your needs, ensuring safety and effectiveness. This therapy is especially useful for patients with heavy metal exposure, cardiovascular concerns, or those seeking to optimize their health and energy.
Benefits of Chelation Infusions:
Detoxification: Removes heavy metals and harmful toxins.
Improved Circulation: Enhances blood flow by reducing arterial plaque.
Boosted Energy: Eliminates toxic burdens that contribute to fatigue.
Heart Health: Reduces cardiovascular risks and supports vascular health.
Support for Chronic Conditions: Aids in managing autoimmune and neurodegenerative disorders.
Medical Article Summary
Chelation therapy involves administering chelating agents such as calcium EDTA (CAEDTA), sodium EDTA (NAEDTA), and DMPS to bind to toxic metals. These complexes are then excreted via the kidneys, reducing the body’s toxic burden. Chelation also benefits vascular health by improving endothelial function and reducing oxidative stress.
Mechanisms of Chelation Therapy
Heavy Metal Binding: Chelating agents attach to heavy metals like lead, mercury, and arsenic for safe removal.
Oxidative Stress Reduction: Decreases free radicals, protecting cells from damage.
Arterial Health: Removes calcium deposits and improves blood vessel flexibility.
Immune System Support: Reduces inflammatory responses triggered by metal toxicity.
Applications of Chelation Therapy
Heavy Metal Toxicity: Effective for lead, mercury, and arsenic poisoning.
Cardiovascular Disease: Improves symptoms of atherosclerosis and reduces arterial plaque.
Neurodegenerative Disorders: Supports conditions like Alzheimer’s by reducing toxic metal accumulation.
Chronic Fatigue and Fibromyalgia: Addresses toxins that exacerbate symptoms.
Clinical Evidence
A 2020 study in Environmental Health Perspectives confirmed the effectiveness of EDTA in reducing blood lead levels and improving vascular health. Additionally, the TACT (Trial to Assess Chelation Therapy) study published in JAMA highlighted significant cardiovascular benefits of chelation therapy, especially for patients with diabetes and prior heart conditions.
Medical Article Link
Link: Chelation Therapy for Heavy Metal Detoxification and Cardiovascular Health
Summary: A 2022 review in Toxicology Reports demonstrated the safety and efficacy of chelation therapy in reducing heavy metal toxicity and improving endothelial function. The study also emphasized the therapy’s potential in managing chronic diseases linked to oxidative stress and inflammation.